Pregnancy Registry Recruitment Notices Should Be Cleared - FDA Guidance
This article was originally published in The Tan Sheet
Executive Summary
Manufacturers will need to balance the "active recruitment" strategies for pregnancy registries urged by FDA with the agency's warning that recruitment efforts must not promote use in pregnant women, a draft guidance on pregnancy registries states.
You may also be interested in...
Pregnancy Safety Data Collection Regulation Under Review, FDA Says
A safety regulation on collecting data related to drug events in pregnant women is under review at the Office of Management & Budget.
Pregnancy Safety Data Collection Regulation Under Review, FDA Says
A safety regulation on collecting data related to drug events in pregnant women is under review at the Office of Management & Budget.
Pregnancy Safety Data Collection Regulation Under Review, FDA Says
A safety regulation on collecting data related to drug events in pregnant women is under review at the Office of Management & Budget.